>>Can’t those monies just be set ignored/aside, like that directed towards ‘climate change’, in the past>?
The White House continually changes party. Looks more like long term planning for when it switches Dem. Their planning would have to take into account how to stop Republicans changing that section if they held both parts of Congress. But the other side does seem to excel at long range planning. You’d think Republicans would have learned to at least assign enough SMART staff to read this stuff before they vote.
Good news methinks...
FDA approves first vaccine for the prevention of Ebola virus disease
FDA News Release (12/19/19)
FDA on Thursday announced the approval of Ervebo, the first agency-approved vaccine for the prevention of Ebola virus disease (EVD), caused by Zaire ebolavirus in individuals aged 18 years and older. The Democratic Republic of the Congo (DRC) is currently experiencing the world’s second largest EVD outbreak. In 2018, the World Health Organization (WHO) and the DRC began to use Ervebo as an investigational vaccine under an expanded access program to help mitigate this outbreak. The approval of Ervebo is supported by a study conducted in Guinea during the 2014-2016 outbreak in individuals aged 18 years and older. The study was a randomized cluster (ring) vaccination study in which 3,537 contacts, and contacts of contacts, of individuals with laboratory-confirmed EVD received either immediate or 21-day delayed vaccination with Ervebo. In a comparison of cases of EVD among 2,108 individuals in the immediate vaccination arm and 1,429 individuals in the delayed vaccination arm, Ervebo was determined to be 100% effective in preventing Ebola cases with symptom onset greater than 10 days after vaccination. The safety of Ervebo was assessed in approximately 15,000 individuals in Africa, Europe and North America. The most commonly reported adverse events were pain, swelling, and redness at the injection site, as well as headache, fever, joint and muscle aches and fatigue. Ervebo is administered as a single-dose injection, and is a live, attenuated vaccine that has been genetically engineered to contain a protein from the Zaire ebolavirus.